Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review

被引:78
作者
Jones, Jennifer L. [1 ]
Mateus, Camilo F. [1 ]
Malcolm, Robert J. [1 ]
Brady, Kathleen T. [1 ,2 ]
Back, Sudie E. [1 ,2 ]
机构
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Ralph H Johnson VA Med Ctr, Charleston, SC USA
来源
FRONTIERS IN PSYCHIATRY | 2018年 / 9卷
关键词
ketamine; substance use disorders; addiction; glutamate; abstinence; CLINICAL-EFFICACY; METAANALYSIS; ANTIDEPRESSANT; DEPRESSION; DEPENDENCE; PSYCHOTHERAPY; MANAGEMENT; ADDICTION; MECHANISM;
D O I
10.3389/fpsyt.2018.00277
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Despite advances in behavioral and pharmacotherapy interventions, substance use disorders (SUDs) are frequently refractory to treatment. Glutamatergic dysregulation has received increasing attention as one common neuropathology across multiple substances of abuse. Ketamine is a potent N-methyl-D-aspartate (NMDA) glutamatergic receptor antagonist which has been found to be effective in the treatment of severe depression. Here we review the literature on the efficacy of ketamine in the treatment of SUDs. Methods: A systematic review of the PubMed, Scopus, and ClinicalTrials.gov databases was undertaken to identify completed and ongoing human studies of the effectiveness of ketamine in the treatment of SUDs between January 1997 and January 2018. Results and conclusion: Seven completed studies were identified. Two studies focused on alcohol use disorder, two focused on cocaine use disorder, and three focused on opioid use disorder. Both cocaine studies found improvements in craving, motivation, and decreased cocaine use rates, although studies were limited by small sample sizes, a homogeneous population and short follow-up. Studies of alcohol and opioid use disorders found improvement in abstinence rates in the ketamine group, with significant between-group effects noted for up to two years following a single infusion, although these were not placebo-controlled trials. These results suggest that ketamine may facilitate abstinence across multiple substances of abuse and warrants broader investigation in addiction treatment. We conclude with an overview of the six ongoing studies of ketamine in the treatment of alcohol, cocaine, cannabis, and opioid use disorders and discuss future directions in this emerging area of research.
引用
收藏
页数:10
相关论文
共 32 条
[11]   Glutamatergic substrates of drug addiction and alcoholism [J].
Gass, Justin T. ;
Olive, M. Foster .
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (01) :218-265
[12]   Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies [J].
Han, Yu ;
Chen, Jianjun ;
Zou, Dezhi ;
Zheng, Peng ;
Li, Qi ;
Wang, Haiyang ;
Li, Pengfei ;
Zhou, Xinyu ;
Zhang, Yuqing ;
Liu, Yiyun ;
Xie, Peng .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 :2859-2867
[13]   Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings A Systematic Review and Meta-analysis [J].
Jonas, Daniel E. ;
Amick, Halle R. ;
Feltner, Cynthia ;
Bobashev, Georgiy ;
Thomas, Kathleen ;
Wines, Roberta ;
Kim, Mimi M. ;
Shanahan, Ellen ;
Gass, C. Elizabeth ;
Rowe, Cassandra J. ;
Garbutt, James C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (18) :1889-1900
[14]  
Jovaisa Tomas, 2006, Medicina (Kaunas), V42, P625
[15]   Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up [J].
Krupitsky, E ;
Burakov, A ;
Romanova, T ;
Dunaevsky, I ;
Strassman, R ;
Grinenko, A .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2002, 23 (04) :273-283
[16]  
Krupitsky EM, 1997, J PSYCHOACTIVE DRUGS, V29, P165
[17]   Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence [J].
Krupitsky, Evgeny M. ;
Burakov, Andrei M. ;
Dunaevsky, Igor V. ;
Romanova, Tatyana N. ;
Slavina, Tatyana Y. ;
Grinenko, Alexander Y. .
JOURNAL OF PSYCHOACTIVE DRUGS, 2007, 39 (01) :13-19
[18]   Experience of the use of Ketamine to manage opioid withdrawal in an addicted woman: a case report [J].
Lalanne, Laurence ;
Nicot, Chloe ;
Lang, Jean-Philippe ;
Bertschy, Gilles ;
Salvat, Eric .
BMC PSYCHIATRY, 2016, 16
[19]   Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy [J].
Mann, Karl ;
Torup, Lars ;
Sorensen, Per ;
Gual, Antoni ;
Swift, Robert ;
Walker, Brendan ;
van den Brink, Wim .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (12) :1941-1949
[20]   Drug dependence, a chronic medical illness - Implications for treatment, insurance, and outcomes evaluation [J].
McLellan, AT ;
Lewis, DC ;
O'Brien, CP ;
Kleber, HD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (13) :1689-1695